Insulet Corporation (PODD)
NASDAQ
Closed
Aug 24, 2026
Day's Range
145.2252 wk Range
126.40Overview - PODD - Insulet Corporation
Key Statistics
Valuation
Enterprise Value
10.68B
P/E (Trailing)
‪27.79‬
P/E (Forward)
‪19.21‬
PEG Ratio
‪0.08‬
Price / Sales (TTM)
‪3.36‬
Price / Book
‪7.22‬
EV / EBITDA
‪17.38‬
Profitability
Gross Margin
‪70.17%‬
Profit Margin
‪12.29%‬
Operating Margin
‪16.17%‬
Return on Assets
‪9.71%‬
Return on Equity
‪26.01%‬
Ownership
Shares Outstanding
69.35M
Float
69.06M
Short % of Shares Outstanding
‪6.24%‬
Held by Insiders
‪0.32%‬
Held by Institutions
‪107.08%‬
Price stats
Beta
‪1.09‬
50-Day Avg
‪154.44‬
200-Day Avg
‪219.16‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
25 analysts
Average price target
‪$ 171.91‬Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - PODD - Insulet Corporation
Peers - PODD - Insulet Corporation
Peer Comparison
Compared with companies in Medical Devices listed on NASDAQ.
- PODDNASDAQInsulet Corporation10.27BMarket Cap-122.06%52-week change27.80P/E (Trailing)‪12.29%‬Profit Margin
- DXCMNASDAQDexCom, Inc.34.84BMarket Cap+17.74%52-week change37.38P/E (Trailing)‪20.11%‬Profit Margin
- GEHCNASDAQGE HealthCare Technologies Inc.33.79BMarket Cap+0.31%52-week change17.24P/E (Trailing)‪9.33%‬Profit Margin
- TLTNASDAQiShares 20+ Year Treasury Bond ETF9.46BMarket Cap-5.03%52-week change—P/E (Trailing)—Profit Margin
- BRKRNASDAQBruker Corporation9.07BMarket Cap+41.89%52-week change74.88P/E (Trailing)‪-2.03%‬Profit Margin
- LILIVNNASDAQLivaNova PLC4.32BMarket Cap+28.16%52-week change23.23P/E (Trailing)‪12.81%‬Profit Margin
- IRTCNASDAQIrhythm Technologies Inc.4.23BMarket Cap-28.91%52-week change-92.51P/E (Trailing)‪-1.69%‬Profit Margin
Profile Summary - PODD - Insulet Corporation
About
Insulet Corporation is a medical device company specializing in insulin delivery technologies for people living with insulin‑dependent diabetes. The company focuses on its Omnipod platform, a family of tubeless, wearable, pod-based insulin management systems designed to provide continuous subcutaneous insulin infusion…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
